The Discounted Cash Flow (DCF) valuation of Meridian Bioscience Inc (VIVO) is 45.90 USD. With the latest stock price at 33.97 USD, the upside of Meridian Bioscience Inc based on DCF is 35.1%.
Based on the latest price of 33.97 USD and our DCF valuation, Meridian Bioscience Inc (VIVO) is a buy. buying VIVO stocks now will result in a potential gain of 35.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 9.1% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 27.18 - 183.55 | 45.90 |
| Upside | -20.0% - 440.3% | 35.1% |